Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
Five Investigational New Drug (IND) applications cleared across a range of therapeutic areas and FDA divisions for lead asset, IMVT-1402Proof of concept data from batoclimab trial in Graves’...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.19 | -4.39926062847 | 27.05 | 28.08 | 25.32 | 1038196 | 26.56437459 | CS |
| 4 | -0.75 | -2.81848928974 | 26.61 | 29.49 | 25.32 | 823415 | 27.63676151 | CS |
| 12 | -2.74 | -9.58041958042 | 28.6 | 32.1 | 24.61 | 793925 | 28.39224732 | CS |
| 26 | -0.02 | -0.0772797527048 | 25.88 | 34.335 | 24.61 | 922835 | 28.91443425 | CS |
| 52 | -10.94 | -29.7282608696 | 36.8 | 45.58 | 24.61 | 1089025 | 31.60258263 | CS |
| 156 | 18.09 | 232.818532819 | 7.77 | 45.58 | 3.145 | 1060809 | 24.35238139 | CS |
| 260 | 9.98 | 62.8463476071 | 15.88 | 53.75 | 3.145 | 919215 | 22.5814 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
